Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2012
09/25/2012US8273734 5HT2C receptor modulators
09/25/2012US8273733 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
09/25/2012US8273548 Nucleic acids encoding a human PAP1 polypeptide
09/25/2012US8273360 Neisseria membrane protein mixture for use in developing vaccine to prevent bacterial infection; bactericides; immunotherapy
09/25/2012US8273358 Activatable clostridial toxins
09/25/2012US8273350 Antibodies to human IL-1β
09/25/2012CA2683124C Aminoalkoxy aryl sulfonamide compounds and their use as 5-ht6 ligands
09/25/2012CA2683040C Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
09/25/2012CA2679530C Benzimidazole compound and pharmaceutical use thereof
09/25/2012CA2664137C Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
09/25/2012CA2557371C Crystalline forms of a pharmaceutical compound
09/25/2012CA2532804C Substituted 2-aminotetralin for the treatment of depression
09/25/2012CA2525524C Combination of the analeptic modafinil and an antidepressant for the treatment of depression
09/25/2012CA2523188C Methods for treatment of parkinson's disease
09/25/2012CA2496688C Glycinamide derivatives as raf-kinase inhibitors
09/25/2012CA2482598C Peptide inhibitors of protein kinase c
09/25/2012CA2478049C Humanized antibodies that recognize beta amyloid peptide
09/20/2012WO2012125809A1 Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen
09/20/2012WO2012125555A1 Method for treating neurodegenerative tauopathy
09/20/2012WO2012125544A2 Necroptosis inhibitors and methods of use therefor
09/20/2012WO2012125518A1 Salt forms of 3 - cyclopropylcarbonyl - 3, 6 - diazabicyclo [3.1.1] heptane
09/20/2012WO2012125413A2 Compositions for ameliorating systemic inflammation and methods for making and using them
09/20/2012WO2012124888A2 Composition comprising the extract of herbal combination for preventing or treating diabetic peripheral neuropathy
09/20/2012WO2012124887A2 Composition comprising the extract of herbs for preventing or treating neurodegenerative disorders
09/20/2012WO2012124817A1 Sprouted cereal, method for manufacturing same, food product containing same, and bdnf production accelerator
09/20/2012WO2012124782A1 Condensed heterocyclic compound
09/20/2012WO2012124696A1 Guanidine compound
09/20/2012WO2012124649A1 Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these
09/20/2012WO2012124631A1 Adjuvant composition containing citrulline
09/20/2012WO2012124311A1 Novel phenylpyridine derivative and drug containing same
09/20/2012WO2012123959A2 Copolymer-1, process for preparation and analytical methods thereof
09/20/2012WO2012123938A1 Quinolone analogs for treating autoimmune diseases
09/20/2012WO2012123922A1 Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor
09/20/2012WO2012123858A1 Amorphous lurasidone hydrochloride
09/20/2012WO2012123563A1 Benz imidazole derivatives as inhibitors of glutaminyl cyclase
09/20/2012WO2012123406A1 Novel use of imidazotriazinones
09/20/2012WO2012123358A1 4r,5r-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity
09/20/2012WO2012123353A1 Novel use of benzofuranylsulfonates
09/20/2012WO2012123325A1 NEW CRYSTAL FORMS OF THE SALT OF TRANS-5-CHLORO-2-METHYL-2,3,3A,12b-TETRAHYDRO-1H-DIBENZO[2,3:6,7]OXEPINO[4,5-c]PYRROLE WITH MALEIC ACID
09/20/2012WO2012123129A1 Solid state crystalline forms of 4-(2-ethyl-5-fluoro-2,3-dihydro-1h-inden-2-yl)-1h-imidazole
09/20/2012WO2012122931A1 Paecilomyces tenuipes strain and applications thereof
09/20/2012WO2012122590A1 Antibody recognizing n-domain of midkine
09/20/2012WO2012098546A8 Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
09/20/2012WO2012089828A3 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
09/20/2012WO2012081859A3 Pharmaceutical composition and functional health food for preventing and treating neurodegenerative diseases
09/20/2012WO2012075500A3 7-deazapurine modulators of histone methyltransferase, and methods of use thereof
09/20/2012WO2012072977A8 Formulations comprising methylthioninium chloride
09/20/2012WO2012031941A3 2-(R²-THIO)-10-[3-(4-R1-PIPERAZIN-1-YL)PROPYL]-10H-PHENOTHIAZINE FOR TREATING A β-AMYLOIDOPATHY OR AN ALPHA-SYNUCLEOPATHY, AND METHOD FOR THE DIAGNOSIS OR PREDIAGNOSIS THEREOF
09/20/2012US20120240247 Jnk3 modulators and methods of use
09/20/2012US20120239007 Implantable Devices and Methods for Treatment of Pain by Delivery of Fentanyl and Fentanyl Congeners
09/20/2012US20120238940 Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures
09/20/2012US20120238639 Pharmaceutical composition comprising propofol
09/20/2012US20120238636 Rasagiline orally disintegrating compositions
09/20/2012US20120238631 Compositions comprising cyclohexylamines and aminoadamantanes
09/20/2012US20120238630 Compositions comprising nonsteroidal anti - inflammatory drugs
09/20/2012US20120238628 Dihydronaphthalene and naphthalene derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators
09/20/2012US20120238627 N-acetyl-l-cysteine for the treatment of endometriosis
09/20/2012US20120238623 Inflammation and Autoimmune Disorder Treatment using RARa Selective Agonists
09/20/2012US20120238615 Alpha adrenergic receptor modulators
09/20/2012US20120238614 Anticonvulsant combination therapy
09/20/2012US20120238597 Inhibiting EPH B-3 Kinase
09/20/2012US20120238593 Heterocyclic compounds and uses thereof
09/20/2012US20120238592 Use and Application of a Pharmaceutical Composition Containing a Mixture of Natural-Origin Heterocylcial Guanidine
09/20/2012US20120238590 Compositions for treating cancer-related fatigue and methods of screening thereof
09/20/2012US20120238589 Organic compounds
09/20/2012US20120238586 Fatty acid acetylated salicylates and their uses
09/20/2012US20120238584 5-HT1A receptor subtype agonist
09/20/2012US20120238582 Quinazoline derivatives
09/20/2012US20120238580 MALEATE SALTS OF 6-(5-CHLORO-2-PYRIDYL)-5-[(4-METHYL-1-PIPERAZINYL)CARBONYLOXY]-7-OXO-6,7-DIHYDRO-5H-PYRROLO[3,4-b]PYRAZINE
09/20/2012US20120238579 New Compounds 806
09/20/2012US20120238578 Compositions useful as inhibitors of voltage-gated sodium channels
09/20/2012US20120238577 Prostaglandin transporter inhibitors and uses thereof
09/20/2012US20120238576 Triazine Derivatives and their Therapeutical Applications
09/20/2012US20120238571 Indazole derivatives as pi 3-kinase
09/20/2012US20120238567 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands
09/20/2012US20120238565 Triazolopyridine compounds and their use as ask inhibitors
09/20/2012US20120238563 Novel unsaturated tetracyclic tetrahydrofuran derivatives
09/20/2012US20120238561 Morpholinothiazoles as alpha 7 positive allosteric modulators
09/20/2012US20120238560 Oxazine Derivatives and their Use in the Treatment of Neurological Disorders
09/20/2012US20120238559 Novel compounds
09/20/2012US20120238557 Aminothiazine or aminooxazine derivative having amino linker
09/20/2012US20120238556 Crystalline methylthioninium chloride hydrates
09/20/2012US20120238553 Novel benzodioxolyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
09/20/2012US20120238552 Pharmaceutical compositions comprising sorbitan esters
09/20/2012US20120238551 Substituted Phenoxypropylcycloamine Derivatives as Histamine-3 (H3) Receptor Ligands
09/20/2012US20120238549 Nuclear Hormone Receptor Modulators
09/20/2012US20120238548 1,4-oxazepines as bace1 and/or bace2 inhibitors
09/20/2012US20120238547 2, 3, 6 - triamino substituted pyridines as kv7 (kcnq) channel modulators
09/20/2012US20120238546 Gamma secretase modulators
09/20/2012US20120238545 Tricyclic pyrazol amine derivatives
09/20/2012US20120238544 Thieno- and furo-pyrimidine modulators of the histamine h4 receptor
09/20/2012US20120238534 Oral suspension of prednisolone acetate
09/20/2012US20120238530 Fatty acid acetylated salicylates and their uses
09/20/2012US20120238526 Aconitine compounds, compositions, uses, and preparation thereof
09/20/2012US20120238511 2-deoxy-d-glucose formulations for prevention or treatment of neurodegenerative diseases
09/20/2012US20120238509 Urocortin 2 analogs and uses thereof
09/20/2012US20120238507 Alpha helical mimics, their uses and methods for their production
09/20/2012US20120238504 Stable Formulations of Botulinum Toxin in Hydrogels
09/20/2012US20120238503 Human laminin alpha2 chain lg3 domain and active peptides promoting cell adhesion, spreading, migration, and neurite outgrowth
09/20/2012US20120238499 Methods of modulating apoptosis by administration of relaxin agonists or antagonists
1 ... 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 ... 1833